These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 7282112)

  • 61. Lichenoid lesions of the oral mucosa in rheumatoid arthritis patients treated with penicillamine.
    Blasberg B; Dorey JL; Stein HB; Chalmers A; Conklin RJ
    J Rheumatol; 1984 Jun; 11(3):348-51. PubMed ID: 6737375
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neuromuscular transmission and acetylcholine receptor antibodies in rheumatoid arthritis patients on D-penicillamine.
    Argov Z; Nicholson L; Fawcett PR; Mastaglia FL; Hall M
    Lancet; 1980 Jan; 1(8161):203. PubMed ID: 6101654
    [No Abstract]   [Full Text] [Related]  

  • 63. [Long-term results of D-penicillamine treatment in rheumatoid arthritis].
    Kutsuna T; Maeda K; Okamoto T
    Ryumachi; 1986 Aug; 26(4):270-7. PubMed ID: 3563727
    [No Abstract]   [Full Text] [Related]  

  • 64. [Autoimmune phenomena in D-penicillamine therapy].
    Kolarz G; Ludwig H; Sabeti M; Scherak O
    Acta Med Austriaca; 1975; 2(4):130-3. PubMed ID: 1083615
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Is myositis in chronic polyarthritis using d-penicillamine drug-induced?].
    Schlumpf U; Bussmann HU; Jerusalem F
    Schweiz Med Wochenschr; 1981 Jan; 111(1):29-35. PubMed ID: 6782670
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A study of the combined effect of ACTH(gel) and D-penicillamine on the functional disability of patients with rheumatoid disease.
    Donnelly P; Cooke D
    J Rheumatol; 1982; 9(6):867-72. PubMed ID: 6298415
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Antibodies to D-penicillamine in patients with chronic polyarthritis--diagnostic aid in undesired and insufficient drug effects?].
    Storch W; Keitel W
    Z Rheumatol; 1988; 47 Suppl 1():44-7. PubMed ID: 3213272
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Myasthenic syndrome during penicillamine treatment (author's transl)].
    Schumm F; Stöhr M
    Klin Wochenschr; 1978 Feb; 56(3):139-44. PubMed ID: 628198
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The failures of D penicillamine].
    Ayrolles C; Guyard C; Fournié A
    Rev Rhum Mal Osteoartic; 1978 Mar; 45(3):161-4. PubMed ID: 653292
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Eosinophilia in rheumatoid patients treated with D-penicillamine.
    Edelman J; Maguire KF; Owen ET
    J Rheumatol; 1984 Oct; 11(5):624-5. PubMed ID: 6512792
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Frequency and prognostic features of rheumatoid patients with remission-inducing agents--a comparison of different kinds of medication].
    Kutsuna T; Maeda K; Okamoto T; Kawaguchi M
    Ryumachi; 1990 Oct; 30(5):336-42. PubMed ID: 2084855
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dermatomyositis induced by penicillamine.
    Simpson NB; Golding JR
    Acta Derm Venereol; 1979; 59(6):543-4. PubMed ID: 94219
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Severe side-effects of treatment with D-penicillamine (author's transl)].
    Hennemann HH; Hubertus H; Stocker WG
    Dtsch Med Wochenschr; 1975 Aug; 100(32):1634-8. PubMed ID: 1172464
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Rheumatoid arthritis, obliterating bronchiolitis and D-penicillamine. Apropos of a new case with ultrastructural examination and review of the literature].
    Geraads A; Brambilla E; Hohn B; Piton JL; Blanc-Jouvan F; Kamel A
    Poumon Coeur; 1983; 39(5):257-62. PubMed ID: 6657554
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diffuse fasciculations induced by D-penicillamine.
    Pinals RS
    J Rheumatol; 1983 Oct; 10(5):809-10. PubMed ID: 6644706
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Thrombotic thrombocytopenic purpura during penicillamine therapy in rheumatoid arthritis.
    Trice JM; Pinals RS; Plitman GI
    Arch Intern Med; 1983 Jul; 143(7):1487-8. PubMed ID: 6683487
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Effect of D-penicillamine on serum immunoglobulins in rheumatoid arthritis].
    Gambari PF; Mioni E; Ostuni A; Volante D; Punzi L; Todesco S; Ongaro G
    Boll Soc Ital Biol Sper; 1981 May; 57(10):1127-31. PubMed ID: 6794580
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [A chemically induced polyneuropathy in chronic polyarthritis treated with D-penicillamine?].
    Mayr N; Graninger W; Wessely P
    Wien Klin Wochenschr; 1983 Feb; 95(3):86-8. PubMed ID: 6305039
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Results of Cuprenil (D-penicillamine) treatment in patients with rheumatoid arthritis].
    Maldykowa H; Chwalińska-Sadowska H; Luft S; Glińska-Urban D; Mikolajew M; Odrzywolska A; Jaworska H
    Reumatologia; 1972; 10(1):9-21. PubMed ID: 5019762
    [No Abstract]   [Full Text] [Related]  

  • 80. Penicillamine-induced myasthenia in rheumatoid arthritis: its clinical and genetic features.
    Delamere JP; Jobson S; Mackintosh LP; Wells L; Walton KW
    Ann Rheum Dis; 1983 Oct; 42(5):500-4. PubMed ID: 6605118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.